DRIVE’s sister project
Advanced therapies are new medical products based on genes or cells, at times in symbiosis with medical devices. They herald revolutionary treatments for a number of chronic diseases including Alzheimer’s and cancer.
The DELIVER programme is a major interdisciplinary effort between cell biologists, experts in biomaterials, medical devices and advanced drug delivery, clinical experts and biotech and biomedical companies focused on academic training and spearheading innovative medical devices for insulin producing cell transplantation.
The DELIVER partners join from 3 EU countries and are Academic (NUI Galway, Eberhard Karls Universitaet Tuebingen, and Royal College of Surgeons in Ireland, Dublin), Industry (Boston Scientific limited, Galway, Explora SRL, Rome) and Clinical (Niguarda Ca’ Granda Hospital, Milan) participants.
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 812865